Keywords: Semaglutide
Marrakesh, November 4, 2025 — The pharmaceutical company Novo Nordisk, in partnership with Laprophan Laboratories, has officially launched Semaglutide in Morocco — an innovative medication designed for patients with type 2 diabetes. The announcement was made......
New research presented at the European Society of Cardiology annual conference in Madrid suggests that weight loss drugs known as GLP-1 agonists could dramatically reduce the risk of hospitalisation and premature death in patients with heart conditions. The study analysed real-world data from over 90,000......
The World Health Organization (WHO) has issued a global alert regarding counterfeit medicines containing semaglutide, a drug used in the treatment of type 2 diabetes and obesity. This stern warning comes in the wake of the detection of falsified batches of semaglutide-based products across multiple countries,......
-
10:05
-
09:45
-
09:32
-
09:15
-
09:00
-
08:43
-
08:25
-
08:10
-
07:59
-
07:55
-
07:47
-
07:46
-
07:35
-
07:31
-
07:30
-
07:28
-
07:17
-
07:17
-
07:15
-
20:00
-
19:21
-
19:05
-
18:45
-
18:30
-
18:15
-
18:00
-
17:43
-
17:25
-
17:10
-
16:45
-
16:26
-
16:12
-
16:10
-
16:02
-
15:50
-
15:47
-
15:32
-
15:23
-
15:19
-
15:15
-
15:00
-
14:44
-
14:28
-
14:26
-
14:22
-
14:10
-
14:02
-
13:47
-
13:41
-
13:37
-
13:30
-
13:15
-
13:08
-
13:00
-
12:42
-
12:27
-
12:21
-
12:05
-
11:45
-
11:38
-
11:28
-
11:11
-
10:47
-
10:44
-
10:32
-
10:26
-
10:23
-
10:15
